SPARC₹171.77-0.76%
79/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %SPARC financial summary
For Mar 2026, Sun Pharma Advanced Research Company Ltd reported revenue of ₹1,879 crore, which grew 2509.7% from the previous year. Net profit was ₹1,552 crore, on an operating margin of 85%. Earnings per share came in at ₹47.83. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹1,879 crore |
|---|---|
| Net profit | ₹1,552 crore |
| Operating margin | 85% |
| EPS | ₹47.83 |